$189.12 +3.28 (%) Illumina Inc - NASDAQ

Oct. 24, 2014 | 04:00 PM

Partner Headlines

  1. Facebook Among 10 IBD 50 Stocks With Rising Estimates

    IBD | Oct. 23, 2014 | 22:43PM EST
  2. Five Leading Stocks Stage Breakouts As Market Rallies

    IBD | Oct. 23, 2014 | 18:24PM EST
  3. Illumina Breaks Out Of Double-Bottom Base

    IBD | Oct. 22, 2014 | 17:01PM EST
  4. Major Indexes End Win Streak; Super Micro Surges

    IBD | Oct. 22, 2014 | 16:24PM EST
  5. Stocks Turn Negative; Ilumina, Manhattan Break Out

    IBD | Oct. 22, 2014 | 13:26PM EST
  6. Stocks Extend Comeback; S&P 500 Retakes 200-Day Line

    IBD | Oct. 21, 2014 | 16:24PM EST
  7. Stocks Further Extend Gains; Airlines, Medicals Soar

    IBD | Oct. 21, 2014 | 15:01PM EST
  8. Harley-Davidson Climbs On Upbeat Earnings; Coca-Cola Shares Dip

    Benzinga | Oct. 21, 2014 | 13:08PM EST
  9. Illumina Stock Soars As Analysts Laud Earnings

    IBD | Oct. 21, 2014 | 12:55PM EST
  10. Stocks Extend Gains At Midday; Akorn Clears Buy Point

    IBD | Oct. 21, 2014 | 12:03PM EST
  11. Markets Surge; McDonald's Posts Lower Sales

    Benzinga | Oct. 21, 2014 | 10:38AM EST
  12. Stocks Post Solid Early Advance; Apple Lifts Nasdaq, S&P 500

    IBD | Oct. 21, 2014 | 10:38AM EST
  13. Benzinga's Top Upgrades

    Benzinga | Oct. 21, 2014 | 10:28AM EST
  14. Janney Capital Upgrades Illumina To Buy

    Benzinga | Oct. 21, 2014 | 10:10AM EST
  15. Stock Futures Point Higher; Earnings Boost Illumina, Apple

    IBD | Oct. 21, 2014 | 08:59AM EST
  16. Benzinga's Top #PreMarket Gainers

    Benzinga | Oct. 21, 2014 | 08:14AM EST
  17. Illumina Pounds Q3 Earnings Estimates, Lifts Guidance

    IBD | Oct. 20, 2014 | 19:08PM EST
  18. Illumina Boosts '14 Guidance

    IBD | Oct. 20, 2014 | 18:57PM EST
  19. Illumina Spikes 10% On Q3 Earnings Beat

    Benzinga | Oct. 20, 2014 | 17:17PM EST
  20. Video: Apple, Chipotle Report Earnings After Close

    IBD | Oct. 20, 2014 | 16:07PM EST
  21. Stock Futures Shedding Losses; Halliburton Gains, IBM Groans

    IBD | Oct. 20, 2014 | 08:59AM EST
  22. Earnings Scheduled For October 20, 2014

    Benzinga | Oct. 20, 2014 | 05:26AM EST
  23. Celgene, Alexion Among 4 IBD 50 Medical s To Report

    IBD | Oct. 18, 2014 | 08:02AM EST
  24. Illumina Helps Make Gene Sequencing Affordable

    IBD | Oct. 17, 2014 | 18:48PM EST
  25. IBD 50: Five Stocks Forming Intriguing Chart Patterns

    IBD | Oct. 17, 2014 | 18:48PM EST
  26. Stocks Up Big Friday, Recover Early Week Losses

    IBD | Oct. 17, 2014 | 16:24PM EST
  27. Illumina Launches New Reagent Kits For HiSeq X Ten And HiSeq 2500 Systems

    Benzinga | Oct. 17, 2014 | 06:34AM EST
  28. Stocks Mixed Going Into Final Hour Of Trading

    IBD | Oct. 16, 2014 | 15:05PM EST
  29. Benzinga's Top Upgrades

    Benzinga | Oct. 16, 2014 | 09:16AM EST
  30. Piper Jaffray Upgrades Illumina To Overweight

    Benzinga | Oct. 16, 2014 | 07:54AM EST
  31. Big Swings in Biotech Short Interest

    Benzinga | Oct. 13, 2014 | 08:32AM EST
  32. Illumina Pads Gene Sequencing Lead With Pharma Deals

    IBD | Oct. 8, 2014 | 16:04PM EST
  33. Stocks Slide At Starting Bell; Keurig Green Mountain Rises

    IBD | Oct. 7, 2014 | 10:28AM EST
  34. UPDATE: BTIG Research Initiates Coverage On Illumina, Inc. On Long-Term Investment Opportunity

    Benzinga | Oct. 3, 2014 | 07:59AM EST
  35. Stocks Sell Off On Europe Worries; Growth Names Slammed

    IBD | Oct. 1, 2014 | 15:04PM EST
  36. Making Money With Charles Payne: 09/26/14

    FoxBusiness | Sep. 26, 2014 | 18:00PM EST
  37. Wave Of Selling Hits Stocks; IPO CyberArk Extends Gains

    IBD | Sep. 25, 2014 | 13:31PM EST
  38. Apple Fuels Tech Sell-Off; Valeant Bucks The Trend

    IBD | Sep. 25, 2014 | 11:34AM EST
  39. Sigma-Aldrich Hits High On Sale To Germany's Merck

    IBD | Sep. 22, 2014 | 11:30AM EST
  40. IBD 50 Names Hold Gains, But Actionable Charts Scarce

    IBD | Sep. 15, 2014 | 14:37PM EST
  41. IBD 50 Names Hold Gains, But Actionable Charts Scarce

    IBD | Sep. 12, 2014 | 19:11PM EST
  42. Does Illumina's Latest Base Have The Profit Gene?

    IBD | Sep. 12, 2014 | 18:20PM EST
  43. Quiet Stocks Are Typical In Market Right Now

    IBD | Sep. 8, 2014 | 18:18PM EST
  44. IBD 50 Showing Little Distress, But Few Big Winners

    IBD | Sep. 5, 2014 | 18:45PM EST
  45. Salix, Gilead Among 5 Top Medical Leaders To Watch

    IBD | Sep. 5, 2014 | 17:06PM EST
  46. Three Stocks Top-Performing Funds Like: Facebook Baidu Gilead

    IBD | Sep. 3, 2014 | 18:28PM EST
  47. Gilead, Jazz Among 4 Top Big Cap Medicals To Watch

    IBD | Aug. 27, 2014 | 08:02AM EST
  48. The 4 Companies Teaming Up For A New Tool To Fight Cancer

    Benzinga | Aug. 25, 2014 | 16:03PM EST
  49. Illumina Joins Drugmakers To Make Cancer Test System

    IBD | Aug. 22, 2014 | 18:57PM EST
  50. Illumina: Making Markets By Unlocking The Genome

    IBD | Aug. 22, 2014 | 14:12PM EST
Trading Center